[Federal Register Volume 61, Number 217 (Thursday, November 7, 1996)]
[Notices]
[Page 57692]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-28625]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute on Drug Abuse (NIDA) Special Emphasis Panel
meetings:
Purpose/Agenda: To evaluate and review grant applications.
Name of Committee: NIDA Special Emphasis Panel.
Date: November 14, 1996.
Time: 1:00 p.m.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Rita Liu, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-2620.
Name of Committee: NIDA Special Emphasis Panel.
Date: November 19-20, 1996.
Time: 9:00 a.m.
Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Khursheed Asghar, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-2620.
Name of Committee: NIDA Special Emphasis Panel.
Date: November 20, 1996.
Time: 8:30 a.m.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Mary C. Custer, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-2620.
This notice is being published less than 15 days prior to the
meetings due to the urgent need to meet timing limitations imposed
by the review and funding cycle.
The meetings will be closed in accordance with provisions set
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The
applications and the discussions could reveal confidential trade
secrets or commercial property such as patentable material and
personal information concerning individuals associated with the
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Scientist Development, Research Scientist Development,
and Research Scientist Awards; 93.278, Drug Abuse National Research
Service Awards for Research Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health)
Dated: October 31, 1996.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 96-28625 Filed 11-6-96; 8:45 am]
BILLING CODE 4140-01-M
